Literature DB >> 9191889

Uncoupling of T-cell antigen receptor and downstream protein tyrosine kinases in common variable immunodeficiency.

M B Majolini1, M M D'Elios, M Boncristiano, P Galieni, G Del Prete, J L Telford, C T Baldari.   

Abstract

Patients with common variable immunodeficiency (CVID) are heterogeneous in the clinical manifestations of the disease and the underlying mechanisms leading to the immunodeficiency. Although the overt defect is an impairment in B-cell function, there is increasing evidence of primary T-cell dysfunctions in a proportion of patients with CVID. We have analyzed T-cells from six CVID patients for activation of both early and late events in response to TCR triggering. The data showed that T-cells from three of six CVID patients were defective in the capacity to initiate the TCR/CD3 signaling pathway by activating intracellular tyrosine kinases, associated with impaired proliferative responses to TCR/CD3 triggering. Since both surface expression of the TCR/CD3 complex and intracellular expression of key tyrosine kinases such as p56lek and ZAP-70 were normal in these patients, our data suggest a defect in the earliest step of TCR signal transduction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9191889     DOI: 10.1006/clin.1997.4372

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  9 in total

Review 1.  Genetics of IgA deficiency and common variable immunodeficiency.

Authors:  H W Schroeder
Journal:  Clin Rev Allergy Immunol       Date:  2000-10       Impact factor: 8.667

Review 2.  Therapeutic strategies in common variable immunodeficiency.

Authors:  W A Carrock Sewell; Matthew Buckland; Stephen R A Jolles
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 3.  Common variable immune deficiency: reviews, continued puzzles, and a new registry.

Authors:  Charlotte Cunningham-Rundles; Adina Kay Knight
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

Review 4.  TACI mutation in common variable immunodeficiency and IgA deficiency.

Authors:  Rima Rachid; Emanuela Castigli; Raif S Geha; Francisco A Bonilla
Journal:  Curr Allergy Asthma Rep       Date:  2006-09       Impact factor: 4.806

5.  Characterization of Herpesvirus saimiri-transformed T lymphocytes from common variable immunodeficiency patients.

Authors:  J A Cabanillas; R Cambronero; A Pacheco-Castro; M C García-Rodríguez; J M Martín-Fernández; G Fontán; J R Regueiro
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

6.  Impaired up-regulation of CD70 and CD86 in naive (CD27-) B cells from patients with common variable immunodeficiency (CVID).

Authors:  C Groth; R Drager; K Warnatz; G Wolff-Vorbeck; S Schmidt; H Eibel; M Schlesier; H-H Peter
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

7.  Defective surface expression of attractin on T cells in patients with common variable immunodeficiency (CVID).

Authors:  N Pozzi; L Gaetaniello; B Martire; D De Mattia; B Balestrieri; E Cosentini; S F Schlossman; J S Duke-Cohan; C Pignata
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

8.  A CVID-associated variant in the ciliogenesis protein CCDC28B disrupts immune synapse assembly.

Authors:  Nagaja Capitani; Anna Onnis; Francesca Finetti; Chiara Cassioli; Alessandro Plebani; Jlenia Brunetti; Arianna Troilo; Sofia D'Elios; Manuela Baronio; Luisa Gazzurelli; Chiara Della Bella; Daniel D Billadeau; Mario Milco D'Elios; Vassilios Lougaris; Cosima T Baldari
Journal:  Cell Death Differ       Date:  2021-07-22       Impact factor: 12.067

9.  Regulatory T cell dysfunction in subjects with common variable immunodeficiency complicated by autoimmune disease.

Authors:  Grace P Yu; David Chiang; Steven J Song; Elisabeth G Hoyte; Jennifer Huang; Christopher Vanishsarn; Kari C Nadeau
Journal:  Clin Immunol       Date:  2009-01-22       Impact factor: 3.969

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.